Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jan 27, 2023; 15(1): 105-113
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Group | n | Before treatment | After 1 mo of treatment | After 3 mo of treatment |
Study group | 49 | 549.8 ± 130.7 | 342.0 ± 96.5 | 184.3 ± 67.8 |
Control group | 49 | 530.6 ± 148.0 | 388.5 ± 86.0 | 219.5 ± 73.0 |
t value | 0.681 | -2.518 | -2.473 | |
P value | 0.498 | 0.013 | 0.015 |
- Citation: Wang L, Huang K, Zhang Y, Wu YF, Yue ZD, Fan ZH, Liu FQ, Li YW, Dong J. Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(1): 105-113
- URL: https://www.wjgnet.com/1948-9366/full/v15/i1/105.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.105